Invacare adds diabetes expert to board
ELYRIA, Ohio – Invacare has appointed Marc Gibeley to its board of directors. Gibeley is the head of diabetes care, North America, for Roche Holding AG and is responsible for all aspects of the company’s blood glucose monitoring and insulin pump business, including sales, marketing, finance, customer support and product launches. “He has a keen understanding of the population that we serve, the ongoing healthcare reform changes that impact our business, and the rise of consumerism in the medical device space,” Invacare stated in a press release. Gibeley is the third new independent director to join Invacare’s board over the past year and a half. He joins the board after a search by a nationally recognized firm.